Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Bridging minds and policies: supporting early career researchers in translating computational psychiatry research
    Published on 2024-02-27
    1 year ago
  • Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward
    Published on 2024-02-25
    1 year ago
  • Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial
    Published on 2024-02-25
    1 year ago
  • Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets
    Published on 2024-02-23
    1 year ago
  • Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach
    Published on 2024-02-22
    1 year ago
  • The sinking platform test: a novel paradigm to measure persistence in animal models
    Published on 2024-02-22
    1 year ago
  • In memoriam: Kenneth E. Moore
    Published on 2024-02-22
    1 year ago
« Previous 1 … 48 49 50 51 52 … 143 Next »
Journal of Psychopharmacology
  • Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample
    Published on 2022-10-03
    3 years ago
  • The low risk for early renal damage during lithium treatment has not changed over time
    Published on 2022-09-19
    3 years ago
  • Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence
    Published on 2022-09-19
    3 years ago
  • The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
    Published on 2022-09-19
    3 years ago
  • Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health
    Published on 2022-09-16
    3 years ago
  • Prefrontal cortex and putamen grey matter alterations in cannabis and tobacco users
    Published on 2022-09-16
    3 years ago
  • Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
    Published on 2022-09-13
    3 years ago
« Previous 1 … 48 49 50 51 52 … 124 Next »
European Neuropsychopharmacology
  • Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis
    Published on 2023-01-28
    2 years ago
  • Number needed to treat and number needed to harm: What are they good for?
    Published on 2023-01-27
    2 years ago
  • Multi-omics data integration methods and their applications in psychiatric disorders
    Published on 2023-01-26
    2 years ago
  • LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals
    Published on 2023-01-20
    2 years ago
  • As in cooking, so in medicine: Doses do matter
    Published on 2023-01-15
    2 years ago
  • Second-generation antipsychotics and seizures – a systematic review and meta-analysis of serious adverse events in randomized controlled trials
    Published on 2023-01-13
    2 years ago
  • The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings
    Published on 2023-01-13
    2 years ago
« Previous 1 … 48 49 50 51 52 … 145 Next »

   Pharma Pub